Meloxicam Completed Phase 2 / 3 Trials for Dysmenorrhea Treatment

IndicationsStatusPurposePhase
CompletedTreatment2 / 3
clinicaltrials.gov IdentifierTitleDrugs
NCT02183025Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea